Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 1
1977 2
1981 1
1983 1
1984 3
1985 3
1986 7
1987 5
1988 15
1989 14
1990 8
1991 12
1992 10
1993 7
1994 10
1995 8
1996 6
1997 3
1998 6
1999 6
2000 5
2001 9
2002 13
2003 7
2004 21
2005 16
2006 13
2007 15
2008 18
2009 17
2010 21
2011 25
2012 20
2013 36
2014 29
2015 41
2016 21
2017 28
2018 39
2019 34
2020 49
2021 55
2022 51
2023 46
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

697 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.
Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers S, Secord AA, Havrilesky L, O'Malley DM, Backes FJ, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi K, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Fader AN, et al. Among authors: hui p. Clin Cancer Res. 2020 Aug 1;26(15):3928-3935. doi: 10.1158/1078-0432.CCR-20-0953. Epub 2020 Jun 29. Clin Cancer Res. 2020. PMID: 32601075 Free PMC article. Clinical Trial.
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.
Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers SK, Secord AA, Havrilesky L, O'Malley DM, Backes F, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi KS, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Fader AN, et al. Among authors: hui p. J Clin Oncol. 2018 Jul 10;36(20):2044-2051. doi: 10.1200/JCO.2017.76.5966. Epub 2018 Mar 27. J Clin Oncol. 2018. PMID: 29584549 Clinical Trial.
Integrated mutational landscape analysis of uterine leiomyosarcomas.
Choi J, Manzano A, Dong W, Bellone S, Bonazzoli E, Zammataro L, Yao X, Deshpande A, Zaidi S, Guglielmi A, Gnutti B, Nagarkatti N, Tymon-Rosario JR, Harold J, Mauricio D, Zeybek B, Menderes G, Altwerger G, Jeong K, Zhao S, Buza N, Hui P, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Odicino F, Pecorelli S, Ardighieri L, Bilguvar K, Quick CM, Silasi DA, Huang GS, Andikyan V, Clark M, Ratner E, Azodi M, Imielinski M, Schwartz PE, Alexandrov LB, Lifton RP, Schlessinger J, Santin AD. Choi J, et al. Among authors: hui p. Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):e2025182118. doi: 10.1073/pnas.2025182118. Proc Natl Acad Sci U S A. 2021. PMID: 33876771 Free PMC article.
Blue-green urine.
Li YT, Chu WL, Hui PC, Yip T, Lui SL. Li YT, et al. Among authors: hui pc. Nephrology (Carlton). 2021 Sep;26(9):749-750. doi: 10.1111/nep.13887. Epub 2021 May 17. Nephrology (Carlton). 2021. PMID: 34002434 No abstract available.
Port-Site Metastasis in Gynecological Malignancies.
Benabou K, Khadraoui W, Khader T, Hui P, Fernandez R, Azodi M, Menderes G. Benabou K, et al. Among authors: hui p. JSLS. 2021 Jan-Mar;25(1):e2020.00081. doi: 10.4293/JSLS.2020.00081. JSLS. 2021. PMID: 33879998 Free PMC article. Review.
Review of Leiomyoma Variants.
Arleo EK, Schwartz PE, Hui P, McCarthy S. Arleo EK, et al. Among authors: hui p. AJR Am J Roentgenol. 2015 Oct;205(4):912-21. doi: 10.2214/AJR.14.13946. AJR Am J Roentgenol. 2015. PMID: 26397344 Review.
Postinfectious cough in adults.
Liang K, Hui P, Green S. Liang K, et al. Among authors: hui p. CMAJ. 2024 Feb 11;196(5):E157. doi: 10.1503/cmaj.231523. CMAJ. 2024. PMID: 38346782 Free PMC article. No abstract available.
KRAS mutation testing in clinical practice.
Perincheri S, Hui P. Perincheri S, et al. Among authors: hui p. Expert Rev Mol Diagn. 2015 Mar;15(3):375-84. doi: 10.1586/14737159.2015.986102. Epub 2014 Dec 9. Expert Rev Mol Diagn. 2015. PMID: 25487540 Review.
697 results